Author(s): Salehi, B ; Sestito, S ; Rapposelli, S ; Peron, G ; Calina, D ; Sharifi-Rad, M ; Sharopov, F ; Martins, N ; Sharifi-Rad, J
Date: 2019
Persistent ID: https://hdl.handle.net/10216/136307
Origin: Repositório Aberto da Universidade do Porto
Subject(s): ABT-418; ABT-594; Analgesics; Epibatidine; Nicotinic acetylcholine receptors
Epibatidine is a natural alkaloid that acts at nicotinic acetylcholine receptors (nAChRs). The present review aims to carefully discuss the affinity of epibatidine and its synthetic derivatives, analogues to nAChRs for a4ß2 subtype, pharmacokinetic parameters, and its role in health. Published literature shows a low affinity and lack of binding of epibatidine and its synthetic analogues to plasma proteins, indicating their availability for metabolism. Because of its high toxicity, the therapeutic use of epibatidine is hampered. However, new synthetic analogs endowed from this molecule have been developed, with a better therapeutic window and improved selectivity. All these aspects are also discussed here. On the other hand, many reports are devoted to structure–activity relationships to obtain optically active epibatidine and its analogues, and to access its pharmacological effects. Although pharmacological results are obtained from experimental studies and only a few clinical trials, new perspectives are open for the discovery of new drug therapies.
